December 23, 2015

Genetically modified mosquitoes developed by Bill Gates could be at the heart of the current Zika outbreak ravaging Brazil, it has emerged.

The carrier of the Zika virus, the Aedes aegypti mosquito, was genetically modified by the British company Oxitec, which has received funding from Bill Gates.

Bill Gates is a high profile supporter of genetically modified mosquitoes. He is also a member of the Good Club together with George Soros who met in New York in 2009 to discuss ways of curbing world overpopulation and disease, according to the media.

This blog has documented the financial links between members of the Good Club, George Soros, Bill Gates and Eli Broad to scientists and organizations at the heart of an apparently orchestrated Ebola outbreak in 2014.

Oxitec has been releasing the genetically modified Aedes aegypti mosquitoes into the wild in Brazil since 2011, ostensibly to battle dengue fever.

In the meantime, it produces up two million genetically modified mosquitoes a week in its factory in Campinas, Brazil.

Now, scientists in Brazil are studying genetic sequences of mosquitoes transmitting the Zika virus and other diseases to see whether changes have occurred that could have generated mutant mosquitoes.

The larvae of genetically modified mosquitoes are supposed to die at the late larvae or early pupae stage unless they are exposed to the antibiotic tetracycline when they have increased survivorship.

Scientists at the Insitut Pasteur in Paris discovered that genetically modified mosquitoes fed on cat food consisting of factory reared chickens fed large amounts of the antibiotic tetracycline had an increased survival rate.

The problem is that tetracyline is widely used. In fact,a study determined that “tetracycline antibiotics are omnipresent compounds found in different ecological compartments.”

“After medication, more than 70 % of tetracycline antibiotics are excreted and released in active form into the environment via urine and feces from humans and animals. Their highly hydrophilic character and low volatility have resulted in significant persistence in the aquatic environment.” [accessed Dec 23, 2015].

And it is highly likely these genetically modified mosquitoes which are surviving due to tetracycline in the environment which are forming new disease carrying genetic strains.

Brazil is suffering an unprecedented explosion of the Zika virus.

The number of suspected Zika-related microcephaly cases surged to 2,782 as of last Satudary, a surge of nearly 16% from the previous week. The number of confirmed deaths shot up to 40 from 29 over the same week.

Brazilian authorities have declared a national emergency over the mosquito borne Zika virus, which has led to thousands of cases of infant brain damage and 40 related deaths this year.

Spreading rapidly to other parts of the world, the mosquito now threatens the southern U.S., Caribbean, Central and South America and Africa.

Cape Verde reported its first Zika infection on Monday.

Millions of the genetically modified mosquitoes Aedes aegypti could soon be released in Florida.

With summer starting in the southern hemisphere, a surge in Zika and other diseases carried by mutant genetically modified mosquitoes developed with the funds of Bill Gates is on the cards.

Genewatch explains the mosquitoes are modified to carry a dominant lethal genetic system by Oxitec, a spin-out company from Oxford University and of Isis Innovation (Oxford University’s technology transfer arm.

“Oxitec’s patented technique for genetically modifying insects is known as RIDL (Release of Insects carrying a Dominant Lethal genetic system). These GM insects are intended to be used as a form of biological control to reduce natural populations of the target
insect when released into the wild.
Oxitec has developed a number of products incorporating its RIDL technology. These include genetically-modified strains of the Yellow Fever mosquito (Aedes aegypti) and the Asian Tiger mosquito (Aedes albopictus): both of these species can transmit dengue fever. Oxitec also has novel strains of agricultural pest insects. A geneticallymodified
pink bollworm strain containing a heritable fluorescent marker and sterilised by exposure to radiation has been tested by the USDA in open field trials. However, pink bollworm containing the RIDL genetic trait has not yet been released in open trials.
Genetically-modified Mediterranean fruit fly, Mexican fruit fly and olive fly have also been developed but have not yet been released.
The focus of this briefing is on Oxitec’s lead strain of Aedes aegypti, OX513A, which has been released in open field trials in the Cayman Islands and is planned for release in field trials in Malaysia shortly.
The OX513A strain of the Aedes aegypti mosquito is genetically engineered to contain a
red fluorescent marker and the RIDL ‘conditional lethality’ trait.5
Conditional lethality
means that the mosquitoes have been engineered to be able to survive to adulthood
only in the presence of tetracycline (an antibiotic used to treat bacterial infections such
as urinary tract infections, chlamydia and acne). GM mosquitoes are bred to adulthood
GeneWatch UK Briefing
December 2010
in the lab in the presence of the antibiotic and males are then released into the

Leave a Reply